BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 38573644)

  • 1. Assessing the feasibility of a multimodal liquid biopsy for the diagnosis of HPV-associated oropharyngeal squamous cell carcinoma.
    Lewis JS; Naegele S; Efthymiou V; Mehrad M; Ely KA; Waterboer T; Lang Kuhs KA; Davis SJ; Richard K; Das D; Faden DL
    Am J Clin Pathol; 2024 Jun; 161(6):570-578. PubMed ID: 38349613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oncological outcomes post transoral robotic surgery (TORS) for HPV-associated oropharyngeal squamous cell carcinoma, a single-centre retrospective Australian study.
    Kornfeld B; Taha A; Kyang L; Sim HW; Dewhurst S; McCloy R; Chin V; Earls P; Parker A; Leavers B; Forstner D; Floros P; Crawford J; Gallagher R
    J Robot Surg; 2024 May; 18(1):226. PubMed ID: 38806847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Double trouble: Synchronous and metachronous primaries confound ctHPVDNA monitoring.
    Naegele S; Efthymiou V; Hirayama S; Zhao BY; Das D; Chan AW; Richmon JD; Iafrate AJ; Faden DL
    Head Neck; 2023 Jun; 45(6):E25-E30. PubMed ID: 37080924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Upfront Neck Dissection for Treatment Selection and Improvement in Quality of Life as a Novel Treatment Paradigm for Deintensification in HPV+ OPSCC.
    Swiecicki PL; Bellile E; Dragovic AF; McHugh J; Udager A; Mierzwa ML; Shah J; Heft-Neal M; Rosko A; Malloy KM; Casper K; Chinn SB; Shuman AG; Stucken C; Chepeha DB; Wolf GT; Bradford CR; Eisbruch A; Prince ME; Worden FP; Spector ME
    Clin Cancer Res; 2024 Jun; 30(11):2393-2401. PubMed ID: 38517480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparing the Diagnostic Performance of Quantitative PCR, Digital Droplet PCR, and Next-Generation Sequencing Liquid Biopsies for Human Papillomavirus-Associated Cancers.
    Naegele S; Ruiz-Torres DA; Zhao Y; Goss D; Faden DL
    J Mol Diagn; 2024 Mar; 26(3):179-190. PubMed ID: 38103593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating Tumor HPV DNA in Patients With Stage I and II HPV-Associated Head and Neck Cancer After Surgery.
    Naegele S; Das D; Hirayama S; Shalhout SZ; Lee H; Richmon JD; Faden DL
    JAMA Otolaryngol Head Neck Surg; 2024 Jun; 150(6):521-523. PubMed ID: 38662357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The molecular characteristics of recurrent/metastatic HPV-positive head and neck squamous cell carcinoma: A systematic review of the literature.
    Flach S; Maniam P; Hey SY; Manickavasagam J
    Clin Otolaryngol; 2024 Jul; 49(4):384-403. PubMed ID: 38658385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transoral Robotic Surgery and Radiation Volume Deintensification in Unknown Primary Squamous Cell Carcinoma of the Neck: The Phase 2 FIND Nonrandomized Controlled Trial.
    de Almeida JR; Martino R; Hosni A; Goldstein DP; Bratman SV; Chepeha DB; Waldron JN; Weinreb I; Perez-Ordonez B; Yu E; Metser U; Hansen AR; Xu W; Su SJ; Kim J
    JAMA Otolaryngol Head Neck Surg; 2024 Jun; 150(6):463-471. PubMed ID: 38602692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quality of Life and Depression Symptoms After Therapy De-Escalation in HPV+ Oropharyngeal Squamous Cell Carcinoma: A Nonrandomized Controlled Trial.
    Panwar A; Shah S; Reid AE; Lydiatt W; Holcomb AJ; Osmolak A; Coughlin A; Militsakh O; Su YB; Mirmiran A; Huang TS; Nolan N; Duckert R; Barney C; Chiu M; Nguyen C; Sayles H; Ganti AK; Lindau R
    JAMA Otolaryngol Head Neck Surg; 2024 May; 150(5):429-435. PubMed ID: 38573597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Impact of Four Smoking Metrics on Survival After Diagnosis with HPV+ Oropharyngeal Cancer.
    Wilkins SG; Shah R; Safranek CW; Shah HP; Mehra S
    Laryngoscope; 2024 Jul; 134(7):3158-3164. PubMed ID: 38294283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Utility of TTMV-HPV DNA in resolving indeterminate findings during oropharyngeal cancer surveillance.
    Roof SA; Jabalee J; Rettig EM; Chennareddy S; Ferrandino RM; Chen S; Posner MR; Genden EM; Chai RL; Sims J; Thrash E; Stern SJ; Kalman NS; Yarlagadda S; Raben A; Clements L; Mendelsohn A; Kaczmar JM; Pandey Y; Bhayani M; Del Vecchio Fitz C; Hanna GJ
    Oral Oncol; 2024 Jun; 155():106874. PubMed ID: 38878355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single-cell analysis reveals cellular and molecular factors counteracting HPV-positive oropharyngeal cancer immunotherapy outcomes.
    Cha J; Kim DH; Kim G; Cho JW; Sung E; Baek S; Hong MH; Kim CG; Sim NS; Hong HJ; Lee JE; Hemberg M; Park S; Yoon SO; Ha SJ; Koh YW; Kim HR; Lee I
    J Immunother Cancer; 2024 Jun; 12(6):. PubMed ID: 38857913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma circulating tumor DNA testing in the management of HPV-associated sinonasal and nasopharyngeal tumors.
    Im E; Kuan EC; Adappa ND; Patel A; Chapurin N
    Int Forum Allergy Rhinol; 2024 Jun; 14(6):1011-1015. PubMed ID: 38716783
    [No Abstract]   [Full Text] [Related]  

  • 14. Preoperative Circulating Tumor HPV DNA and Oropharyngeal Squamous Cell Disease.
    Lam D; Sangal NR; Aggarwal A; Rajasekaran K; Cannady SB; Basu D; Chalian A; Weinstein G; Brody RM
    JAMA Otolaryngol Head Neck Surg; 2024 May; 150(5):444-450. PubMed ID: 38573644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human papillomavirus circulating tumor DNA: a diagnostic tool in squamous cell carcinoma of unknown primary-a pilot study.
    Kais A; Santiago SP; Han PC; Clump DA; Stokes WA; Fancy T; Cui R; Martin E; Turner MT
    Front Oncol; 2024; 14():1376595. PubMed ID: 38628671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell-free human papillomavirus DNA kinetics after surgery for human papillomavirus-associated oropharyngeal cancer.
    O'Boyle CJ; Siravegna G; Varmeh S; Queenan N; Michel A; Pang KCS; Stein J; Thierauf JC; Sadow PM; Faquin WC; Wang W; Deschler DG; Emerick KS; Varvares MA; Park JC; Clark JR; Chan AW; Busse PM; Corcoran RB; Wirth LJ; Lin DT; Iafrate AJ; Richmon JD; Faden DL
    Cancer; 2022 Jun; 128(11):2193-2204. PubMed ID: 35139236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of Pretreatment Circulating Tumor Tissue-Modified Viral HPV DNA With Clinicopathologic Factors in HPV-Positive Oropharyngeal Cancer.
    Rettig EM; Wang AA; Tran NA; Carey E; Dey T; Schoenfeld JD; Sehgal K; Guenette JP; Margalit DN; Sethi R; Uppaluri R; Tishler RB; Annino DJ; Goguen LA; Jo VY; Haddad RI; Hanna GJ
    JAMA Otolaryngol Head Neck Surg; 2022 Dec; 148(12):1120-1130. PubMed ID: 36301568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. It is time to improve the diagnostic workup of oropharyngeal cancer with circulating tumor HPV DNA: Systematic review and meta-analysis.
    Paolini F; Campo F; Iocca O; Manciocco V; De Virgilio A; De Pascale V; Moretto S; Dalfino G; Vidiri A; Blandino G; Pimpinelli F; Venuti A; Pellini R
    Head Neck; 2023 Nov; 45(11):2945-2954. PubMed ID: 37715656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Role of Transoral Robotic Surgery in the Management of HPV Negative Oropharyngeal Squamous Cell Carcinoma.
    Sload R; Silver N; Jawad BA; Gross ND
    Curr Oncol Rep; 2016 Sep; 18(9):53. PubMed ID: 27469262
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.